Published online Oct 6, 2020. doi: 10.12998/wjcc.v8.i19.4416
Peer-review started: May 6, 2020
First decision: June 18, 2020
Revised: June 26, 2020
Accepted: August 26, 2020
Article in press: August 26, 2020
Published online: October 6, 2020
Processing time: 144 Days and 17.4 Hours
Pancreatic cancer (PC) is a major cause of cancer-related deaths worldwide. Its prognosis is poor, and curative-intent surgery remains the only approach for improving survival rates of PC patients. However, fewer than 20% of PC patients are eligible for surgery following diagnosis, due to local disease progression and metastasis. Therefore, avoiding risk factors as well as early diagnosis represent the most essential approaches for improving the survival of PC patients.
Previous studies have revealed several risk factors for PC including diabetes, smoking and chronic pancreatitis. Although chronic pancreatitis has been associated with PC, the relationship between acute pancreatitis (AP) and PC risk remains unclear due to inconsistent and contradictory results.
We explored the association between AP and PC risk using a meta-analysis of retrospective and prospective studies.
We first searched PubMed, Web of Science, Cochrane, and EMBASE databases for original articles associating AP with PC using. We then calculated combined overall effect estimates (EEs) between AP and PC risk at a 95% confidence interval (CI), using a random-effects model and assessed heterogeneity using the I2 test. Thereafter, we examined the relationship between AP and PC using combined relative risk (RR), at 95%CI. Furthermore, we conducted publication bias and subgroup analyses, then analyzed sensitivities to explain the observed heterogeneity.
Eleven studies were eligible for inclusion in this meta-analysis, and resulted in a pooled EE of 2.07 (95%CI: 1.36-2.78) for AP and PC risk. Additionally, five prospective cohort studies reported 103961 patients in the AP group, relative to 1442158 subjects in the control group, with a pooled RR of 7.81 (95%CI: 5.00-12.19). Subgroup analyses, performed using different follow-up times, revealed pooled EEs of 23.47 (95%CI: 3.26-43.68), 9.82, (95%CI: 3.01-16.64), 2.47 (95%CI: 1.93-3.02), 1.69 (95%CI: 1.26-2.11) and 1.17 (95%CI: 0.78-1.57) for 1, 2, 5, 10 and > 10-year lag periods, respectively. Similar analyses targeting the type of research methods revealed EEs of 3.03 (95%CI: -1.02 to 7.08, P = 0.141) and 2.09 (95%CI: 1.22-2.97) for case-control sand cohort studies, respectively.
Overall, our findings indicated an association between AP and PC risk. Based on subgroup analyses, AP is unlikely to be a causal factor for PC.
Although AP might not be a direct cause for PC risk, its occurrence could be an indicators for PC. Future studies are expected to elucidate the association between AP and PC risk across different follow-up times, in order to improve early PC diagnosis.